SOW
RYTM icon

State of Wyoming’s Rhythm Pharmaceuticals RYTM Stock Holding History

State of Wyoming’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705K Buy
+6,354
New +$574K 0.07% 242
2026
Q1 		– Sell
-2,441
Closed -$261K – 2001
2025
Q4 		$261K Buy
2,441
+1,487
+156% +$158K 0.03% 796
2025
Q3 		$96.3K Sell
954
-111
-10% -$10.3K 0.01% 1311
2025
Q2 		$67.3K Buy
+1,065
New +$65.2K 0.01% 1411
2025
Q1 		– Sell
-1,084
Closed -$60.7K – 1823
2024
Q4 		$60.7K Buy
+1,084
New +$59.9K 0.01% 1342
2023
Q2 		– Sell
-1,126
Closed -$20.1K – 1748
2023
Q1 		$20.1K Sell
1,126
-1,102
-49% -$27.7K 0.01% 1421
2022
Q4 		$64.9K Buy
+2,228
New +$57.3K 0.02% 962
2022
Q2 		– Sell
-249
Closed -$3K – 2099
2022
Q1 		$3K Buy
249
+41
+20% +$360 ﹤0.01% 1689
2021
Q4 		$2K Sell
208
-11
-5% -$124 ﹤0.01% 1781
2021
Q3 		$3K Sell
219
-73
-25% -$1.11K ﹤0.01% 1138
2021
Q2 		$6K Buy
292
+201
+221% +$4.17K ﹤0.01% 1060
2021
Q1 		$2K Buy
+91
New +$2.64K ﹤0.01% 476

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State of Wyoming's RYTM Position: Q2 2026 in Review

State of Wyoming opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 6,354 shares worth $705K. The stake represents 0.07% of the portfolio and ranks #242 among its holdings. This is a return to the name: State of Wyoming previously reported a position in RYTM as recently as Q4 2025.

State of Wyoming first reported a position in RYTM in Q1 2021 and has held it in 12 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • State of Wyoming held 6,354 shares of Rhythm Pharmaceuticals worth $705K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new State of Wyoming position in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.07% of State of Wyoming's portfolio in Q2 2026, its #242 holding.
  • State of Wyoming first reported a position in Rhythm Pharmaceuticals in Q1 2021 and has held it in 12 quarters since.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.